ClinicalTrials.Veeva

Menu

ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)

R

Ramsay Générale de Santé

Status

Unknown

Conditions

Endometriosis

Treatments

Procedure: MRI

Study type

Observational

Funder types

Other

Identifiers

NCT05153512
2018-A01354-51

Details and patient eligibility

About

To date, no MRI study has been published describing the prevalence of endometriosis in adolescent girls, not even in those with significant dysmenorrhea and therefore more particularly at risk. Likewise, there are no precise data on the type of superficial or early-onset deep endometriosis that appears in adolescence. The collection of these data would allow an earlier diagnosis, because it is better documented, of endometriosis. The lesions would then be treated earlier, avoiding their development and the problems of infertility related to this pathology. The aim of this sudy is to assess the prevalence of endometriosis and its phenotypic representation in the study population consulting for dysmenorrhea with suspected endometriosis.

Enrollment

350 estimated patients

Sex

Female

Ages

12 to 20 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient aged between 12 and 20 years old.
  • After menarche.
  • Requiring pelvic MRI for exploration of dysmenorrhea (after or not ultrasound), in the case of patients with suspected endometriosis, or for any other reason (cyst, tumor, non-obstructive urogenital malformations), in the case of patients without symptoms clinic associated with endometriosis.
  • Patient affiliated or beneficiary of a social security scheme.
  • Patient and her legal representative, if applicable, having been informed and not opposing this research.

Exclusion criteria

  • Patient whose pelvic MRI is performed as part of an exploration of obstructive uterine malformations.
  • Patient claustrophobic, making it impossible to perform an MRI.
  • Contraindication to MRI: pacemaker, ferromagnetic object incompatible with MRI.
  • Pregnant, breastfeeding or parturient woman.
  • Protected patient: Major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision; Hospitalized without consent.

Trial contacts and locations

1

Loading...

Central trial contact

Jean-François Oudet; Marie-Hélène Barba

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems